NCT05488951

Brief Summary

The primary aim of this study is to conduct a pilot 6-month assessor-blinded randomized controlled trial to determine if the Otago Exercise Program plus usual care improves executive function in people living with mild to moderate dementia compared to usual care among those living in a nursing home or assisted living facility. The exploratory aims are to determine if the Otago Exercise Program plus usual care improves inflammatory blood biomarkers, kynurenine metabolites, epigenetics, mobility, balance, cognition, mood, fall-related self-efficacy, health-related quality of life, sleep, physical activity, and falls by sex and race compared to usual care alone among people living with mild to moderate dementia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

July 28, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 5, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

January 31, 2023

Status Verified

January 1, 2023

Enrollment Period

1.5 years

First QC Date

July 28, 2022

Last Update Submit

January 30, 2023

Conditions

Keywords

DementiaOtago Exercise ProgramExecutive Function

Outcome Measures

Primary Outcomes (1)

  • Change in the Color Word Stroop Test

    Response inhibition involves deliberately suppressing dominant, automatic, or prepotent responses, and will be assessed using the Stroop Colour-Word Test. For the Stroop Test, there will be three conditions. First, participants will be asked to read aloud words printed in black ink (e.g., BLUE). Second, they were instructed to read aloud the color of colored rectangles. Finally, they will shown a page of color-words printed in incongruent colored ink (e.g., the word "BLUE" printed in red ink). Participants will be asked to name the ink color in which the words are printed (while ignoring the word itself). There will 50 trials for each condition and the time taken to read each condition will recorded.

    Baseline, 6 months

Secondary Outcomes (52)

  • Change in the Digit Symbol Substitution Test

    Baseline, 6 months

  • Change in the oral Trail Making Test

    Baseline, 6 months

  • Change in the Digit Span Forwards and Backwards

    Baseline, 6 months

  • Change in the Rey Auditory Verbal Learning Test

    Baseline, 6 months

  • Change in the Benton Judgement of Line Orientation

    Baseline, 6 months

  • +47 more secondary outcomes

Other Outcomes (6)

  • Montreal Cognitive Assessment

    Baseline

  • Morse Fall Scale

    Baseline

  • Cornell Depression Scale

    Baseline

  • +3 more other outcomes

Study Arms (2)

Otago Exercise Program Plus Usual Care

EXPERIMENTAL

The Otago Exercise Program will be led by a physical therapist in a group setting (5-7 participants/exercise class). The exercise will be 20 min of walking and 30 min of strength and balance exercises 3x/week for 6 months. The physical therapist will select suitable exercises for each participant, such that the exercise is individualized and progressive. Participants will also receive usual care from health care providers (e.g., specialist and local doctor visits, community nurse visits, paid care provider visits, hospitalizations as required, and any ongoing treatment for any illness and/or their comorbidities).

Other: Otago Exercise Program

Usual Care Only

NO INTERVENTION

Usual care will consist of routine care from their health care providers (e.g., specialist and local doctor visits, community nurse visits, paid care provider visits, hospitalizations as required, and any ongoing treatment for any illness and/or their comorbidities).

Interventions

The Otago Exercise Program will be led by a physical therapist in a group setting (5-7 participants/exercise class). The exercise will be 20 min of walking and 30 min of strength and balance exercises (i.e., 50 min exercise class) 3x/week for 6 months. The physical therapist will select suitable exercises for each participant, such that the exercise is individualized and progressive.

Otago Exercise Program Plus Usual Care

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 55 years and older
  • Reside in a nursing home or assisted living facility
  • Have any type of mild to moderate dementia confirmed by medical records and/or a physician
  • Can read, write, and speak English with acceptable visual and auditory acuity
  • Able to walk 3 meters with or without the assistance of another person
  • Have a legally authorized representative who can provide informed consent
  • Able to provide assent
  • Able to understand and follow instructions
  • Have a life expectancy of ≥12 months as estimated by a healthcare provider

You may not qualify if:

  • Reside in the community
  • Severe dementia (e.g., Montreal Cognitive Assessment ≤6/30) and are not able to follow instructions
  • Severe psychiatric condition
  • Delirium
  • Acute medical condition
  • Medical condition precluding exercise (e.g., unstable cardiac disease)
  • Recent surgery affecting mobility
  • Enrolled in another research study
  • Blindness
  • Aphasia
  • Enrolled in another research study
  • Receiving hospice care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Augusta University

Augusta, Georgia, 30912, United States

RECRUITING

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Deborah A Jehu, PhD

    Augusta University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Deborah A Jehu, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The investigators conducting the testing will be masked to group assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: For this pilot study, participants will be randomly assigned (1:1) to the exercise (n=21) or control group (n=21). The statisticians (Dr Jennifer Waller and Dr. Brittany Ange) will generate the randomization sequence and provide it to the study coordinator after the baseline assessment; they will also conceal the treatment allocation from the assessors. Randomization will be stratified by biological sex (female/male) and study site. Blocked randomization will be performed using random block sizes of 2 and 4. Permutations of exercise or control will be performed in each block.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 28, 2022

First Posted

August 5, 2022

Study Start

July 1, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

January 31, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations